(Q34730855)

English

CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy (English)

1 reference

Europe PubMed Central

4 August 2017

0 references

Heiner Grosskurth

object named as

Heiner Grosskurth

9

0 references

Charles F. Gilks

object named as

Charles Gilks

7

0 references

Pontiano Kaleebu

10

object named as

Pontiano Kaleebu

1 reference

Europe PubMed Central

4 August 2017

Ann Sarah Walker

5

object named as

Sarah Walker

1 reference

Europe PubMed Central

4 August 2017

author name string

Jennifer Serwanga

1

1 reference

Europe PubMed Central

4 August 2017

Susan Mugaba

2

1 reference

Europe PubMed Central

4 August 2017

Auma Betty

3

1 reference

Europe PubMed Central

4 August 2017

Edward Pimego

4

1 reference

Europe PubMed Central

4 August 2017

Paula Munderi

6

1 reference

Europe PubMed Central

4 August 2017

Frances Gotch

8

1 reference

Europe PubMed Central

4 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 January 2011

1 reference

Europe PubMed Central

4 August 2017

AIDS Research and Treatment

1 reference

Europe PubMed Central

4 August 2017

2011

1 reference

Europe PubMed Central

4 August 2017

875028

1 reference

Europe PubMed Central

4 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Geographic HIV type 1 subtype distribution in Rakai district, Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Impact of MHC class I diversity on immune control of immunodeficiency virus replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

CD4 deficits and disease course acceleration can be driven by a collapse of the CD8 response in rhesus macaques infected with simian immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/microl

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

CD4+ count-guided interruption of antiretroviral treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

CD8+ cell depletion amplifies the acute retroviral syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Structured Treatment Interruption: Approaches and Risks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Structured treatment interruptions to control HIV-1 and limit drug exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

A molecular epidemiologic survey of HIV in Uganda. HIV Variant Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

7 July 2018

Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals.

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Structured interruptions of therapy: looking for the best protocol

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Human immunodeficiency virus-type 1 specific cellular immunity in chronic infected patients on prolonged highly active antiretroviral treatment and on structured treatment interruption

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Control of HIV despite the Discontinuation of Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065901

26 October 2018

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Cross-Clade CD8+ T-Cell Responses With a Preference for the Predominant Circulating Clade

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Effect of Highly Active Antiretroviral Therapy on Viral Burden in the Lungs of HIV‐Infected Subjects

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Determinants of Virologic and Immunologic Outcome in Chronically HIV-Infected Subjects Undergoing Repeated Treatment Interruptions

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F875028

21 January 2018

Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/21490785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21490785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/21490785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21490785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2011/875028

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34730855&oldid=1994903917"